BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217
7 results:

  • 1. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
    J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TRIM29 regulates the setbp1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
    Qiao HY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Yan J; Li C; Wang HQ
    Cancer Lett; 2022 Mar; 529():85-99. PubMed ID: 34973391
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TGFαL3-seb fusion protein as an anticancer against ovarian cancer.
    Maleki F; Sadeghifard N; Sedighian H; Bakhtiyari S; Hosseini HM; Fooladi AAI
    Eur J Pharmacol; 2020 Mar; 870():172919. PubMed ID: 31935394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients.
    Battaglia A; Fossati M; Buzzonetti A; Scambia G; Fattorossi A
    Immunol Lett; 2017 Nov; 191():35-39. PubMed ID: 28919454
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
    Michailidou K; Beesley J; Lindstrom S; Canisius S; Dennis J; Lush MJ; Maranian MJ; Bolla MK; Wang Q; Shah M; Perkins BJ; Czene K; Eriksson M; Darabi H; Brand JS; Bojesen SE; Nordestgaard BG; Flyger H; Nielsen SF; Rahman N; Turnbull C; ; Fletcher O; Peto J; Gibson L; dos-Santos-Silva I; Chang-Claude J; Flesch-Janys D; Rudolph A; Eilber U; Behrens S; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Khan S; Aaltonen K; Ahsan H; Kibriya MG; Whittemore AS; John EM; Malone KE; Gammon MD; Santella RM; Ursin G; Makalic E; Schmidt DF; Casey G; Hunter DJ; Gapstur SM; Gaudet MM; Diver WR; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Berg CD; Chanock SJ; Figueroa J; Hoover RN; Lambrechts D; Neven P; Wildiers H; van Limbergen E; Schmidt MK; Broeks A; Verhoef S; Cornelissen S; Couch FJ; Olson JE; Hallberg E; Vachon C; Waisfisz Q; Meijers-Heijboer H; Adank MA; van der Luijt RB; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Yoo KY; Matsuo K; Ito H; Iwata H; Tajima K; Guénel P; Truong T; Mulot C; Sanchez M; Burwinkel B; Marme F; Surowy H; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; González-Neira A; Benitez J; Zamora MP; Perez JI; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; ; ; Lindblom A; Margolin S; Teo SH; Yip CH; Taib NA; Tan GH; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Blot W; Signorello LB; Cai Q; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Shen CY; Hsiung CN; Wu PE; Hou MF; Kristensen VN; Nord S; Alnaes GI; ; Giles GG; Milne RL; McLean C; Canzian F; Trichopoulos D; Peeters P; Lund E; Sund M; Khaw KT; Gunter MJ; Palli D; Mortensen LM; Dossus L; Huerta JM; Meindl A; Schmutzler RK; Sutter C; Yang R; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Chia KS; Chan CW; Fasching PA; Hein A; Beckmann MW; Haeberle L; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Ashworth A; Orr N; Schoemaker MJ; Swerdlow AJ; Brinton L; Garcia-Closas M; Zheng W; Halverson SL; Shrubsole M; Long J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Hamann U; Brüning T; ; Radice P; Peterlongo P; Manoukian S; Bernard L; Bogdanova NV; Dörk T; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska K; Huzarski T; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Kabisch M; Torres D; Neuhausen SL; Anton-Culver H; Luccarini C; Baynes C; Ahmed S; Healey CS; Tessier DC; Vincent D; Bacot F; Pita G; Alonso MR; Álvarez N; Herrero D; Simard J; Pharoah PP; Kraft P; Dunning AM; Chenevix-Trench G; Hall P; Easton DF
    Nat Genet; 2015 Apr; 47(4):373-80. PubMed ID: 25751625
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Texosome-anchored superantigen triggers apoptosis in original ovarian cancer cells.
    Mahmoodzadeh Hosseini H; Soleimanirad J; Mehdizadeh Aghdam E; Amin M; Imani Fooladi AA
    Med Oncol; 2015 Jan; 32(1):409. PubMed ID: 25452173
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Screening for ovarian cancer: what are the optimal surrogate endpoints for clinical trials?
    Karlan BY
    J Cell Biochem Suppl; 1995; 23():227-32. PubMed ID: 8747401
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.